Skip to main content

Advertisement

Log in

Contemporary management of large-volume arteriovenous malformations: a clinician’s review

  • Review
  • Published:
Journal of Radiation Oncology

Abstract

Arteriovenous malformations (AVMs) represent a heterogeneous group of lesions, and as such, there exist several treatment options and approaches depending on size, location, grading, and symptoms. Large-volume AVMs represent a particularly challenging subset of AVMs with controversy over the very classification with definitions based on size, volume, and Spetzler-Martin grade. With regards to treatment paradigms, the natural history of these lesions is an important foundation upon which management principles have been built. At this time, management options range from observation with medical management to interventions including radiosurgery, microsurgery, embolization, or a combination of these approaches. In light of the challenges facing clinicians, we performed a literature review of AVMs with a specific focus on the management of large-volume AVMs with respect to outcomes, toxicity, and future treatment options. Based on the review, we have proposed a comprehensive risk-based treatment algorithm for the management of large-volume AVMs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Lunsford DL KD, Niranjan A, Lindquist C, et al. Stereotactic radiosurgery for patients with intracranial arteriovenous malformations (AVM) Radiosurgery Practice Guideline Report #2-03

  2. Braksick SA, Fugate JE (2015) Management of brain arteriovenous malformations. Curr Treat Options Neurol 17:358

    Article  PubMed  Google Scholar 

  3. Zhao J, Yu T, Wang S et al (2010) Surgical treatment of giant intracranial arteriovenous malformations. Neurosurgery 67:1359–1370

    Article  PubMed  Google Scholar 

  4. Yang W, Hung AL, Caplan JM (2016) Delayed hemorrhage after treatment of brain arteriovenous malformations (AVMs). World Neurosurg 87:98–109

    Article  PubMed  Google Scholar 

  5. Yang SY, Kim DG, Chung HT et al (2009) Radiosurgery for large cerebral arteriovenous malformations. Acta Neurochir 151:113–124

    Article  PubMed  Google Scholar 

  6. Maruyama K, Kawahara N, Shin M et al (2005) The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations. N Engl J Med 352:146–153

    Article  CAS  PubMed  Google Scholar 

  7. Miyawaki L, Dowd C, Wara W et al (1999) Five year results of LINAC radiosurgery for arteriovenous malformations: outcome for large AVMS. Int J Radiat Oncol Biol Phys 44:1089–1106

    Article  CAS  PubMed  Google Scholar 

  8. Inoue HK, Ohye C (2002) Hemorrhage risks and obliteration rates of arteriovenous malformations after gamma knife radiosurgery. J Neurosurg 97:474–476

    Article  PubMed  Google Scholar 

  9. Blackburn SL, Ashley WW Jr, Rich KM et al (2011) Combined endovascular embolization and stereotactic radiosurgery in the treatment of large arteriovenous malformations. J Neurosurg 114:1758–1767

    Article  PubMed  Google Scholar 

  10. Stefani MA, Porter PJ, terBrugge KG et al (2002) Large and deep brain arteriovenous malformations are associated with risk of future hemorrhage. Stroke 33:1220–1224

    Article  PubMed  Google Scholar 

  11. Chung WY, Shiau CY, Wu HM et al (2008) Staged radiosurgery for extra-large cerebral arteriovenous malformations: method, implementation, and results. J Neurosurg 109(Suppl):65–72

    PubMed  Google Scholar 

  12. Spetzler RF, Martin NA (1986) A proposed grading system for arteriovenous malformations. J Neurosurg 65:476–483

    Article  CAS  PubMed  Google Scholar 

  13. Pollock BE, Flickinger JC (2002) A proposed radiosurgery-based grading system for arteriovenous malformations. J Neurosurg 96:79–85

    Article  PubMed  Google Scholar 

  14. Mohr JP, Parides MK, Stapf C et al (2014) Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet 383:614–621

    Article  CAS  PubMed  Google Scholar 

  15. Dalyai R, Theofanis T, Starke RM et al (2014) Stereotactic radiosurgery with neoadjuvant embolization of larger arteriovenous malformations: an institutional experience. BioMed Research International 2014:306518

    Article  PubMed  PubMed Central  Google Scholar 

  16. Kano H, Kondziolka D, Flickinger J et al (2012) Stereotactic radiosurgery for arteriovenous malformations, Part 6: multistaged volumetric management of large arteriovenous malformations. J Neurosurg 116:54–65

    Article  PubMed  Google Scholar 

  17. Wedderburn CJ, van Beijnum J, Bhattacharya JJ et al (2008) Outcome after interventional or conservative management of unruptured brain arteriovenous malformations: a prospective, population-based cohort study. Lancet Neurol 7:223–230

    Article  PubMed  Google Scholar 

  18. Laakso A, Dashti R, Seppanen J et al (2008) Long-term excess mortality in 623 patients with brain arteriovenous malformations. Neurosurgery 63:244–253

    Article  PubMed  Google Scholar 

  19. Plasencia AR, Santillan A (2012) Embolization and radiosurgery for arteriovenous malformations. Surg Neurol Int 3:S90–S104

    Article  PubMed  PubMed Central  Google Scholar 

  20. Davidson AS, Morgan MK (2010) How safe is arteriovenous malformation surgery? A prospective, observational study of surgery as first-line treatment for brain arteriovenous malformations. Neurosurgery 66:498–504

    Article  PubMed  Google Scholar 

  21. Spetzler RF, Martin NA, Carter LP et al (1987) Surgical management of large AVM’s by staged embolization and operative excision. J Neurosurg 67:17–28

    Article  CAS  PubMed  Google Scholar 

  22. Finitsis S, Anxionnat R, Bracard S et al (2005) Symptomatic radionecrosis after AVM stereotactic radiosurgery. Study of 16 consecutive patients. Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology. Surgical Procedures and Related Neurosciences 11:25–33

    CAS  Google Scholar 

  23. Back AG, Vollmer D, Zeck O et al (2008) Retrospective analysis of unstaged and staged Gamma Knife surgery with and without preceding embolization for the treatment of arteriovenous malformations. J Neurosurg 109(Suppl):57–64

    PubMed  Google Scholar 

  24. Veznedaroglu E, Andrews DW, Benitez RP et al (2004) Fractionated stereotactic radiotherapy for the treatment of large arteriovenous malformations with or without previous partial embolization. Neurosurgery 55:519–530

    Article  PubMed  Google Scholar 

  25. Sirin S, Kondziolka D, Niranjan A et al (2006) Prospective staged volume radiosurgery for large arteriovenous malformations: indications and outcomes in otherwise untreatable patients. Neurosurgery 58:17–27

    Article  PubMed  Google Scholar 

  26. Foote KD, Friedman WA, Ellis TL et al (2003) Salvage retreatment after failure of radiosurgery in patients with arteriovenous malformations. J Neurosurg 98:337–341

    Article  PubMed  Google Scholar 

  27. Xiao F, Gorgulho AA, Lin CS et al (2010) Treatment of giant cerebral arteriovenous malformation: hypofractionated stereotactic radiation as the first stage. Neurosurgery 67:1253–1259

    Article  PubMed  Google Scholar 

  28. Starke RM, Kano H, Ding D et al (2016) Stereotactic radiosurgery for cerebral arteriovenous malformations: evaluation of long-term outcomes in a multicenter cohort. J Neurosurg 4:1–9

    Article  Google Scholar 

  29. Chytka T, Liscak R, Kozubikova P et al (2015) Radiosurgery for large arteriovenous malformations as a single-session or staged treatment. Stereotact Funct Neurosurg 93:342–347

    Article  PubMed  Google Scholar 

  30. van Beijnum J, van der Worp HB, Buis DR et al (2011) Treatment of brain arteriovenous malformations: a systematic review and meta-analysis. JAMA 306:2011–2019

    Article  PubMed  Google Scholar 

  31. Pan JW, Zhou HJ, Zhan RY et al (2009) Supratentorial brain AVM embolization with Onyx-18 and post-embolization management. A single-center experience. Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical procedures and Related Neurosciences 15:275–282

    CAS  Google Scholar 

  32. Song DL, Leng B, Xu B et al (2007) Clinical experience of 70 cases of cerebral arteriovenous malformations embolization with Onyx, a novel liquid embolic agent. Chinese Journal of Surgery 45:223–225

    Google Scholar 

  33. Katsaridis V, Papagiannaki C, Aimar E (2008) Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients. Neuroradiology 50:589–597

    Article  PubMed  Google Scholar 

  34. Panagiotopoulos V, Gizewski E, Asgari S et al (2009) Embolization of intracranial arteriovenous malformations with ethylene-vinyl alcohol copolymer (Onyx). AJNR Am J Neuroradiol 30:99–106

    Article  CAS  PubMed  Google Scholar 

  35. Weber W, Kis B, Siekmann R et al (2007) Preoperative embolization of intracranial arteriovenous malformations with Onyx. Neurosurgery 61:244–252

    Article  PubMed  Google Scholar 

  36. Starke RM, Komotar RJ, Otten ML et al (2009) Adjuvant embolization with N-butyl cyanoacrylate in the treatment of cerebral arteriovenous malformations: outcomes, complications, and predictors of neurologic deficits. Stroke 40:2783–2790

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Vinuela F, Dion JE, Duckwiler G et al (1991) Combined endovascular embolization and surgery in the management of cerebral arteriovenous malformations: experience with 101 cases. J Neurosurg 75:856–864

    Article  CAS  PubMed  Google Scholar 

  38. Ogilvy CS, Stieg PE, Awad I et al (2001) AHA Scientific Statement: recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke 32:1458–1471

    Article  CAS  PubMed  Google Scholar 

  39. Ding XWZ (2006) The study of different type of cerebral arteriovenous malformation embolization with NBCA and ONYX. Chin J Neurosurg 8:464–466

    Google Scholar 

  40. Chao ST, Ahluwalia MS, Barnett GH et al (2013) Challenges with the diagnosis and treatment of cerebral radiation necrosis. Int J Radiat Oncol Biol Phys 87:449–457

    Article  PubMed  Google Scholar 

  41. Deibert CP, Ahluwalia MS, Sheehan JP et al (2013) Bevacizumab for refractory adverse radiation effects after stereotactic radiosurgery. J Neurooncol 115:217–223

    Article  CAS  PubMed  Google Scholar 

  42. Wong ST, Loo KT, Yam KY et al (2010) Results of excision of cerebral radionecrosis: experience in patients treated with radiation therapy for nasopharyngeal carcinoma. J Neurosurg 113:293–300

    Article  PubMed  Google Scholar 

  43. Rowe J, Grainger A, Walton L et al (2007) Risk of malignancy after gamma knife stereotactic radiosurgery. Neurosurgery 60:60–65

    PubMed  Google Scholar 

  44. Vernimmen FJAI (2014) Vascular endothelial growth factor blockade: a potential new therapy in the management of cerebral arteriovenous malformations. Journal of Medical Hypotheses and Ideas 8:57–61

    Article  CAS  Google Scholar 

  45. Frenzel T, Lee CZ, Kim H et al (2008) Feasibility of minocycline and doxycycline use as potential vasculostatic therapy for brain vascular malformations: pilot study of adverse events and tolerance. Cerebrovasc Dis 25:157–163

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John H. Suh.

Ethics declarations

Funding

None

Conflicts of interest

John Suh is a consultant of Varian Medical Systems. Samuel Chao is on the Speaker’s Bureau Varian Medical Systems. Peter Rasmussen is an investor and on the Scientific Advisory Board for Blockade Medical, is a Scientific Advisory Board for Covidien/Medtronic, is on the Scientific Advisory Board, is a Stock Holder in Perflow Medical, and is on the Scientific Advisory Board for Stryker Neurovascular. Nikhil Joshi declares that he has no conflict of interest. Chirag Shah declares that he has no conflict of interest. Rupesh Kotecha declares that he has no conflict of interest. Erin Murphy declares that she has no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any other authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Joshi, N.P., Shah, C., Kotecha, R. et al. Contemporary management of large-volume arteriovenous malformations: a clinician’s review. J Radiat Oncol 5, 239–248 (2016). https://doi.org/10.1007/s13566-016-0261-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13566-016-0261-8

Keywords

Navigation